Compare

IGF-1 LR3 vs MOTS-c

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

IGF-1 LR3

30 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 97% · Mixed 3% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Recovery
171

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Water retention
5

Self-reported dose per injection

Median bucket: 50–100 mcg · Most common: 10–25 mcg

Reports span 0–200 mcg

0–10
1
10–25
60
25–50
1
50–100
53
100–200
56

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 96% said they felt similar to their last entry, 4% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 153 days · Based on 28 repeat reporters

MOTS-c

111 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 17% · Mixed 2% · Unfavorable overall 81%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite
230
Energy
45
Mood
1
Recovery
1

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
191

Self-reported dose per injection

Median bucket: 2–3 mg · Most common: 5+ mg

Reports span 0.01 to ≥ 5 mg (open-ended top bucket)

0.01–0.025 mg
4
0.1–0.2 mg
1
0.2–0.4 mg
8
0.4–0.6 mg
11
0.6–1 mg
8
1–2 mg
42
2–3 mg
44
3–5 mg
7
5+ mg
106

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 56% said they felt similar to their last entry, 31% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 44 days · Based on 45 repeat reporters

Explore other peptides